MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MP-23-0031817
Razenta Pharmaceuticals Private Limited
Razenta Pharmaceuticals Private Limited - chemicals in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹3.34 Cr
▲ 70% YoY
Net profit · FY 2025
₹22.18 Lakh
Net margin 6.6%
EBITDA · FY 2025
₹31.07 Lakh
EBITDA margin 9.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Razenta Pharmaceuticals Private Limited
Data last updated:
Razenta Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 08 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24299MP2021PTC057399.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pushpendra Kumar Tiwari and Rajesh Kumar Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 Amans Alid B. Block 575 R Mahalaxmi Nagar, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.34 Cr, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹22.18 Lakh (net margin 6.6%) and EBITDA of ₹31.07 Lakh (EBITDA margin 9.3%).
Court records list 1 case involving the company, including 1 filed against it.
Razenta Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0031817).
Company details
CIN U24299MP2021PTC057399
Registration Number 057399
Incorporation Date 08 September 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0031817
Key People
Nirmal Gangwani Additional Director Yunus Ahamad Additional Director Pushpendra Kumar Tiwari Director Recognitions & Rankings of Razenta Pharmaceuticals
Contact details
Razenta Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address202 Amans Alid B. Block 575 R Mahalaxmi Nagar, Indore, Madhya Pradesh, India – 452010
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Razenta Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Razenta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Razenta Pharmaceuticals Private Limited, buy the company report.
Financials of Razenta Pharmaceuticals Private Limited
FY 2025 filings availableRazenta Pharmaceuticals Private Limited reported revenue of ₹3.34 Cr (up 70% YoY) for FY 2025.
Revenue · FY 2025
₹3.34 Cr ▲ 70%
Net profit · FY 2025
₹22.18 Lakh margin 6.6%
EBITDA · FY 2025
₹31.07 Lakh margin 9.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 70%
EBITDA CAGR growth
1 year
▲ 387%
3 years · compounded
▲ 373%
Revenue rose 70% in the latest year. EBITDA rose 387% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹31.07 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹22.18 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.3% | |||
| Net Profit Margin | 6.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Razenta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Razenta Pharmaceuticals Private Limited
Razenta Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Gangwani | Additional Director | 01 Mar 2022 | 4 Years 7 Months | Current |
| Yunus Ahamad | Additional Director | 01 Nov 2021 | 4 Years 11 Months | Current |
| Pushpendra Kumar Tiwari | Director | 08 Sep 2021 | 5 Years 1 Months | Current |
| Rajesh Kumar Tiwari | Director | 08 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Razenta Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lipur Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2024) | 33.0% | Patna, Bihar, India | |||
| Maclan Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2025) | 9.0% | Jaipur, Rajasthan, India | |||
| Torin Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Razenta Pharmaceuticals Private Limitedthis company | ₹3.34 Cr (FY 2025) | ₹22.18 Lakh | 6.6% | 70.0% | Indore, Madhya Pradesh, India | |
| Wunderz Pharmaceuticals Private Limited | ₹3.33 Cr (FY 2024) | -2.0% | Kochi, Kerala, India | |||
| Hyeto Pharmaceuticals Private Limited | ₹3.33 Cr (FY 2025) | 2163.0% | Ranchi, Jharkhand, India | |||
| C'estlavie Pharmaceuticals Private Limited | ₹3.31 Cr (FY 2025) | 7.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Razenta Pharmaceuticals Private Limited, buy the company report.
Legal cases
Razenta Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Dr. Reddys Laboratories Limited | Disposed |
To see the full case history of Razenta Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Razenta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Razenta Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Razenta Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Nirmal Gangwani was appointed as Additional Director on 01 Mar 2022.
AGM
Razenta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Razenta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Nirmal Gangwani was appointed as Additional Director.
Appointed
Yunus Ahamad was appointed as Additional Director.
Appointed
Pushpendra Kumar Tiwari was appointed as Director.
Appointed
Rajesh Kumar Tiwari was appointed as Director.
Incorporation
08 Sep 2021
Razenta Pharmaceuticals Private Limited was registered on 08 Sep 2021 with Roc Gwalior & aged 5 years 1 month as per MCA records.
Frequently asked questions
Razenta Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 08 September 2021 (5+ years old) and is registered under CIN U24299MP2021PTC057399.
Razenta Pharmaceuticals has 4 current directors:
- Nirmal Gangwani - Additional Director
- Yunus Ahamad - Additional Director
- Pushpendra Kumar Tiwari - Director
- Rajesh Kumar Tiwari - Director
The latest financial statements of Razenta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Razenta Pharmaceuticals is U24299MP2021PTC057399. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Razenta Pharmaceuticals has 1 court case on record: 1 filed against it.
Razenta Pharmaceuticals was incorporated on 08 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Razenta Pharmaceuticals by revenue are Lipur Pharmaceuticals Private Limited, Maclan Pharmaceuticals Private Limited, Torin Pharmaceuticals Private Limited, Wunderz Pharmaceuticals Private Limited, Hyeto Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nirmal Gangwani was appointed as Additional Director on 01 Mar 2022. Yunus Ahamad was appointed as Additional Director on 01 Nov 2021. Pushpendra Kumar Tiwari was appointed as Director on 08 Sep 2021. Razenta Pharmaceuticals has 4 board changes on record in total.
Yes, Razenta Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0031817).
The registered office of Razenta Pharmaceuticals is at 202 Amans Alid B. Block 575 R Mahalaxmi Nagar, Indore, Madhya Pradesh, India – 452010.
Razenta Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages